title: Low-density lipoprotein composition and oxidation are not influenced by calcineurin inhibitors in renal transplant patients.
authors.affiliation: Department of Biochemistry, Lapeyronie University Hospital, Montpellier, France.
authors.forename: M
authors.initials: M
authors.lastname: Morena
authors.forename: C
authors.initials: C
authors.lastname: Vela
authors.forename: V
authors.initials: V
authors.lastname: Garrigue
authors.forename: J
authors.initials: J
authors.lastname: Catanzano
authors.forename: B
authors.initials: B
authors.lastname: Descomps
authors.forename: J P
authors.initials: JP
authors.lastname: Cristol
authors.forename: G
authors.initials: G
authors.lastname: Mourad
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D065095:Calcineurin Inhibitors; D002784:Cholesterol / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction; D016559:Tacrolimus / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
chemical_list: D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D008077:Lipoproteins, LDL; D014280:Triglycerides; C099252:oxidized low density lipoprotein; D016572:Cyclosporine; D002784:Cholesterol; D001379:Azathioprine; D016559:Tacrolimus